Articles & Press Releases

Read the SVS letter to CMS

R. Clement Darling III, MD, was elected president-elect of the Society for Vascular Surgery (SVS) at the 2016 Vascular Annual Meeting in June.

Dr. Michel S. Makaroun, a professor of surgery and of clinical and translational science at the University of Pittsburgh, was elected vice president of the Society for Vascular Surgery (SVS) at the Society’s 2016 Vascular Annual Meeting in June.

[[{"type":"media","view_mode":"media_large","fid":"840","attributes":{"alt":"","class":"media-image","height":"480","style":"width: 177px; height: 198px; float: left; margin-left: 8px; margin-right: 8px;","typeof":"foaf:Image","width":"430"}}]]CHICAGO, Ill., July 11, 2016  — Vascular surgeon

CHICAGO, Ill., July 11, 2016 — As he completed his term as president of the Society for Vascular Surgery (SVS), Dr. Bruce A. Perler began his term as chair of the SVS Foundation at the society’s 2016 Vascular Annual Meeting near Washington, D.C. in June.

The variety of endovascular devices and techniques to treat occlusive disease has exploded over the past 10 years and critical evaluation of the reported results may be problematic. The Society for Vascular Surgery has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease. Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.

A new reporting standards document on Endovascular Treatment of Chronic Lower Extremity Peripheral Arterial Disease (PAD) has been posted on the website of the July 2016 issue of the Journal of Vascular Surgery. Lead authors are Drs. Mike Stoner and Keith Calligaro.

Call him profoundly influential – but also call him ‘Jack’

This year’s Lifetime Achievement Award winner gets called a lot of things by his many nominators: quadruple hitter, visionary, mentor, revolutionary, unsurpassed, profoundly effective.

The unique relationship that vascular surgeons enjoy with their patients has enabled our specialty to have a special claim on the way we care for patients. Outgoing SVS President Bruce Perler spoke during the 2016 Vascular Annual Meeting near Washington, D.C. on June 10.

‘CAN YOU SAVE MY LEG?’
RESEARCHERS NOW HAVE A BETTER ANSWER FOR PATIENTS

A groundbreaking trial needs more patients enrolled – quickly – and the SVS is asking for your help.

CHICAGO, Illinois - Conventional wisdom might suppose that everyone would avoid surgery if possible.

Society for Vascular Surgery Honors Nurses

CHICAGO, Illinois, May 6, 2016 –The Society for Vascular Surgery Board of Directors is pleased to announce Kenneth M. Slaw, Ph.D., as the society’s next executive director, replacing Rebecca Maron, CAE, who will retire May 30, 2016.  

NIH GRANT and SVS award support RESEARCH ON GUT MICROBES’ EFFECT ON restenosis

Chicago, Illinois– Could microbes in the gut impact human arteries? Surprising early research suggests they might play a role.

The Society for Vascular Surgery and the SVS Foundation present a number of awards during the Vascular Annual Meeting. The achievements and special efforts of many also receive special recognition. 

While the 2016 Vascular Annual Meeting includes postgraduate courses, hands-on workshops and other courses, it also features special lectures and forums that add to attendees' overall understanding of the treatment of vascular diseases. Special VAM events include:

Update on the Medicare Value-Based Payment Modifier and Electronic Health Record Incentive Program Requirements

 

SVS Quality and Performance Measures Committee Provides Information on National Changes

CHICAGO, Illinois - Previous studies have shown that women are more likely than men to die after vascular surgery, but a new study shows that they are far more likely to be readmitted to the hospital after aortic aneurysm surgery as well.

A letter to members from SVS President Dr. Bruce A. Perler and SVS PAC Steering Committee Chair Dr. Randall DeMartino:

CHICAGO, Illinois, March 31, 2016 - For some vascular surgery patients, starting an antiplatelet and a cholesterol medication after surgery can significantly extend their lives, even if they don’t have

A recent review of patients who had undergone carotid, lower extremity bypass, or abdominal aortic aneurysm surgeries found that patients who received both statins and antiplatelet medications were far more likely to be alive five years later. Patients placed on both an antiplatelet agent and cholesterol medication had an adjusted 40 percent reduced risk of death at five years compared to those who received neither drug. Being on either one of these medications was also important, and was associated with an adjusted 30 percent reduced risk of death compared to those on neither medication. When considered differently, an extra 14 of every 100 patients were alive at five years if on both medications.

Executive search firm conducting national search for new director

CHICAGO, Illinois - Society for Vascular Surgery Executive Director Rebecca Maron has announced her retirement, effective the end of May. She has served in that position for 13 years.

All too often patients say they are "blindsided" by unexpected outcomes of surgery. SVS member Dr. Margaret "Gretchen" Schwarze has won a prestigious PCORI grant to study ways to help patients understand what major surgery will mean to them.